Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov;48(11):1387-1391.
doi: 10.1111/cup.14080. Epub 2021 Jun 16.

A rare case of syringocystadenocarcinoma papilliferum of the breast: An institutional retrospective case review and brief literature review

Affiliations
Review

A rare case of syringocystadenocarcinoma papilliferum of the breast: An institutional retrospective case review and brief literature review

Jeffrey D McBride et al. J Cutan Pathol. 2021 Nov.

Abstract

Syringocystadenocarcinoma papilliferum (SCACP) is a rare cutaneous adnexal tumor thought to originate from its benign counterpart, syringocystadenoma papilliferum. These tumors are predominantly located on the head and neck with their location on the breast extraordinarily reported; mammary localization poses a great diagnostic dilemma to the practicing pathologist. Herein, we report an unusual case of an 85-year-old woman with an outside diagnosis on a core needle biopsy of metaplastic mammary carcinoma. Upon consultative review of the partial mastectomy specimen, SCACP was identified. Herein, we review SCACP and the diagnostic challenge it poses, especially when localized to the breast. Furthermore, we perform a retrospective review of institutional pathology reports and identified four additional cases of SCACP diagnosed at our institution within the last decade. Finally, we briefly review the literature of SCACP. The entity of SCACP should be well known to pathologists to avoid misdiagnosis.

Keywords: breast; breast carcinoma; invasive carcinoma; metaplastic carcinoma; syringocystadenocarcinoma papilliferum; syringocystadenoma papilliferum.

PubMed Disclaimer

References

REFERENCES

    1. Altunel E, Perepletchikov A, Kozyreva O. Metastatic syringocystadenocarcinoma papilliferum: a case report, tumor genomic profiling, and literature review. Case Rep Oncol Med. 2020;2020:9056209. https://doi.org/10.1155/2020/9056209.
    1. Dissanayake RV, Salm R. Sweat-gland carcinomas: prognosis related to histological type. Histopathology. 1980;4(4):445-466.
    1. Zhang Y, Kong YY, Cai X, Shen XX, Kong JC. Syringocystadenocarcinoma papilliferum: clinicopathologic analysis of 10 cases. J Cutan Pathol. 2017;44(6):538-543.
    1. Arslan H, Diyarbakrl M, Batur S, Demirkesen C. Syringocystadenocarcinoma papilliferum with squamous cell carcinoma differentiation and with locoregional metastasis. J Craniofac Surg. 2013;24(1):e38-e40.
    1. Peterson J, Tefft K, Blackmon J, Rajpara A, Fraga G. Syringocystadenocarcinoma papilliferum: a rare tumor with a favorable prognosis. Dermatol Online J. 2013;19(9):19620.

LinkOut - more resources